Latest News about ARGX

Recent news which mentions ARGX

< Previous 1 2 3 4 5 6 7 8 Next >

Argenx's Drug Scores European Approval For Muscular Fatigue Disorder

August 11, 2022

Argenx's Vyvgart To 'Achieve Blockbuster Status,' This Analyst Says With 6% Price Target Hike

July 29, 2022

Benzinga's Top Ratings Upgrades, Downgrades For July 29, 2022

July 29, 2022

argenx SE (ARGX) Q2 2022 Earnings Call Transcript

July 28, 2022

Daily Biotech Pulse: GSK's Kidney Disease Drug Approved For Children, Tonix Pharma To Launch Monkeypox Vaccine Study In Kenya, Positive Effect Of Cyclerion's Schizophrenia Candidate

July 28, 2022

argenx: Q2 Earnings Insights

July 28, 2022

Recap: argenx Q2 Earnings

July 28, 2022

Piper Sandler Maintains Overweight Rating for argenx: Here's What You Need To Know

July 25, 2022

What 5 Analyst Ratings Have To Say About argenx

July 25, 2022

SVB Sees Strategic Value In This Stock As M&A Target In Autoimmune Space

May 24, 2022

Golden Cross Appears Before argenx Investors

May 16, 2022

argenx SE (ARGX) Q1 2022 Earnings Call Transcript

May 06, 2022

Argenx's Vyvgart Meets Primary Goal In Late-Stage Bleeding Disorder Study

May 05, 2022

The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study

May 05, 2022

Recap: argenx Q1 Earnings

May 05, 2022

Benzinga's Top Ratings Upgrades, Downgrades For May 3, 2022

May 03, 2022

This is what you should do in the stock market now, according to three 2022 fund-award winners

April 07, 2022

Argenx's Vyvgart Long-Term Treatment Shows Improved gMG Disease Scores

April 05, 2022

The Daily Biotech Pulse: Thervance Gains On Positive Late-Stage Readout, Bristol-Myers Squibb Snags 3 Approvals In Europe, Decision Day For BioXcel

April 05, 2022

The Daily Biotech Pulse: Pfizer Reports Positive Ulcerative Colitis Study Data, Novavax COVID Shot Authorized For Adolescents In India, Argenx Stock Sale

March 23, 2022

Piper Comments On Increased Interest To Invest In Arcturus, 'Incrementally Positive' On Argenx

March 22, 2022

Argenx's Subcutaneous Efgartigimod At Par With Intravenous Administration In Neuromuscular Disorder

March 22, 2022

The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Pfizer Strikes COVID-19 Pill Supply Deal, Argenx Reports Positive Late-Stage Readout

March 22, 2022

What 8 Analyst Ratings Have To Say About argenx

March 07, 2022

argenx SE (ARGX) Q4 2021 Earnings Call Transcript

March 03, 2022

Recap: argenx Q4 Earnings

March 03, 2022

Earnings Scheduled For March 3, 2022

March 03, 2022

argenx's Earnings: A Preview

March 02, 2022

12 biotech stocks to consider buying now as prospects for the sector brighten this year

February 06, 2022

The Daily Biotech Pulse: Novavax COVID Shot Authorized In Australia, Zymeworks Restructures, Orphan Drug Designation For Marker's Pancreatic Cancer Drug

January 20, 2022

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.